Participate in the HiFlo phase III trial of home High Flow Nasal Therapy (HFNT) via myAirvo 3.

myAirvo 3 is a High Flow Nasal Therapy (HFNT) being offered to COPD patients via a clinical trial. The myAirvo 3 device is a humidifier with integrated flow generator that delivers warmed and humidified respiratory gases to the patient. Researchers are evaluating whether the device increases the time to when a patient experiences a COPD flareup, if it reduces flareup frequency, reduces hospitalization, improves quality of life, as well as other factors.

View study NCT05204888 myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home on ClinicalTrials.gov